Pei‐Qing Gu

773 total citations · 1 hit paper
12 papers, 587 citations indexed

About

Pei‐Qing Gu is a scholar working on Genetics, Pharmacology and Epidemiology. According to data from OpenAlex, Pei‐Qing Gu has authored 12 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Genetics, 4 papers in Pharmacology and 3 papers in Epidemiology. Recurrent topics in Pei‐Qing Gu's work include Inflammatory Bowel Disease (6 papers), Pharmacological Effects of Natural Compounds (4 papers) and NF-κB Signaling Pathways (2 papers). Pei‐Qing Gu is often cited by papers focused on Inflammatory Bowel Disease (6 papers), Pharmacological Effects of Natural Compounds (4 papers) and NF-κB Signaling Pathways (2 papers). Pei‐Qing Gu collaborates with scholars based in China. Pei‐Qing Gu's co-authors include Lei Zhu, Hong Shen, Hong Shen, Lei Zhu, Lu Zhang, Ya‐Jun Liu, Yajun Liu, Jiafei Cheng, Lu Zhang and Lu Zhang and has published in prestigious journals such as Medicine, Biomedicine & Pharmacotherapy and International Immunopharmacology.

In The Last Decade

Pei‐Qing Gu

12 papers receiving 584 citations

Hit Papers

Protective effects of berberine hydrochloride on DSS-indu... 2019 2026 2021 2023 2019 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pei‐Qing Gu China 7 260 198 151 116 86 12 587
Gaiyan Ren China 8 212 0.8× 124 0.6× 126 0.8× 66 0.6× 104 1.2× 8 498
Zengfeng Pan China 12 285 1.1× 142 0.7× 116 0.8× 52 0.4× 133 1.5× 17 556
Gong Yang China 11 227 0.9× 155 0.8× 99 0.7× 41 0.4× 99 1.2× 23 491
Feifei Nong China 10 300 1.2× 115 0.6× 75 0.5× 71 0.6× 75 0.9× 15 487
Lei Zhu China 18 609 2.3× 245 1.2× 145 1.0× 91 0.8× 135 1.6× 58 1.0k
Muxia Li China 14 294 1.1× 75 0.4× 97 0.6× 123 1.1× 48 0.6× 19 564
Yugen Chen China 12 358 1.4× 110 0.6× 90 0.6× 37 0.3× 74 0.9× 26 593
Aning Sun China 14 441 1.7× 202 1.0× 208 1.4× 116 1.0× 244 2.8× 16 1.0k
Ziwen Yuan China 13 364 1.4× 106 0.5× 124 0.8× 45 0.4× 36 0.4× 25 547
Bei Yue China 15 299 1.1× 110 0.6× 95 0.6× 44 0.4× 71 0.8× 21 557

Countries citing papers authored by Pei‐Qing Gu

Since Specialization
Citations

This map shows the geographic impact of Pei‐Qing Gu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei‐Qing Gu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei‐Qing Gu more than expected).

Fields of papers citing papers by Pei‐Qing Gu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei‐Qing Gu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei‐Qing Gu. The network helps show where Pei‐Qing Gu may publish in the future.

Co-authorship network of co-authors of Pei‐Qing Gu

This figure shows the co-authorship network connecting the top 25 collaborators of Pei‐Qing Gu. A scholar is included among the top collaborators of Pei‐Qing Gu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei‐Qing Gu. Pei‐Qing Gu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Shen, Hong, Shengsheng Zhang, Wenxia Zhao, et al.. (2021). Randomised clinical trial: Efficacy and safety of Qing-Chang-Hua-Shi granules in a multicenter, randomized, and double-blind clinical trial of patients with moderately active ulcerative colitis. Biomedicine & Pharmacotherapy. 139. 111580–111580. 18 indexed citations
3.
Jia, Jia, Hong Shen, Ping Zhu, et al.. (2020). Qingchang Huashi granule ameliorates experimental colitis via restoring the dendritic cell-mediated Th17/Treg balance. BMC Complementary Medicine and Therapies. 20(1). 291–291. 5 indexed citations
4.
Pei, Lixia, Hao Chen, Yajun Liu, et al.. (2020). [Analysis on acupoint selection rules for reflux esophagitis].. PubMed. 40(5). 557–64. 2 indexed citations
5.
Zhu, Lei, Hong Shen, Pei‐Qing Gu, et al.. (2020). Baicalin alleviates TNBS‑induced colitis by inhibiting PI3K/AKT pathway activation. Experimental and Therapeutic Medicine. 20(1). 581–590. 52 indexed citations
6.
Zhu, Lei, Hong Shen, Pei‐Qing Gu, et al.. (2019). Qing Chang Hua Shi granule ameliorate inflammation in experimental rats and cell model of ulcerative colitis through MEK/ERK signaling pathway. Biomedicine & Pharmacotherapy. 116. 108967–108967. 25 indexed citations
7.
Zhu, Lei, Pei‐Qing Gu, & Hong Shen. (2019). Protective effects of berberine hydrochloride on DSS-induced ulcerative colitis in rats. International Immunopharmacology. 68. 242–251. 201 indexed citations breakdown →
8.
Zhu, Lei, Jiafei Cheng, Pei‐Qing Gu, et al.. (2019). Therapeutic strategies of thromboembolic events in patients with inflammatory bowel diseases. Medicine. 98(9). e14622–e14622. 5 indexed citations
9.
Zhu, Lei, Pei‐Qing Gu, & Hong Shen. (2018). Gallic acid improved inflammation via NF-κB pathway in TNBS-induced ulcerative colitis. International Immunopharmacology. 67. 129–137. 133 indexed citations
10.
Gu, Pei‐Qing, et al.. (2017). Protective effects of paeoniflorin on TNBS-induced ulcerative colitis through inhibiting NF-kappaB pathway and apoptosis in mice. International Immunopharmacology. 50. 152–160. 125 indexed citations
11.
Zhu, Lei, Yajun Liu, Hong Shen, Pei‐Qing Gu, & Lu Zhang. (2017). Astragalus and Baicalein Regulate Inflammation of Mesenchymal Stem Cells (MSCs) by the Mitogen-Activated Protein Kinase (MAPK)/ERK Pathway. Medical Science Monitor. 23. 3209–3216. 18 indexed citations
12.
Zhang, Shengsheng, Wenxia Zhao, Tao Zhou, et al.. (2012). Clinical observation of sequential stages of Chinese medicine treatment on mild to moderate ulcerative colitis. Zhonghua zhongyiyao zazhi. 27(7). 1788–1791. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026